-
2
-
-
0017712007
-
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calciumphosphorous metabolism
-
Mosekilde L., Flemming M., Bagger J.P., Myhre-Jensen O., Sorensen N.S. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calciumphosphorous metabolism. Acta. Endocrinologica. 1976, 85:515-525.
-
(1976)
Acta. Endocrinologica.
, vol.85
, pp. 515-525
-
-
Mosekilde, L.1
Flemming, M.2
Bagger, J.P.3
Myhre-Jensen, O.4
Sorensen, N.S.5
-
4
-
-
0022411495
-
Trabecular bone remodeling and bone balance in hyperparathyroidism
-
Eriksen E.F., Mosekilde L., Melsen F. Trabecular bone remodeling and bone balance in hyperparathyroidism. Bone 1985, 6:421-428.
-
(1985)
Bone
, vol.6
, pp. 421-428
-
-
Eriksen, E.F.1
Mosekilde, L.2
Melsen, F.3
-
5
-
-
0029849166
-
Spontaneous release of interleukin 1 b from human blood monocytes in thyrotoxic osteodystrophy
-
Bisbocci D., Gallo V., Damiano P., Sidoli L., Cantoni R., Aimo G., Priolo G., Pagni R., Chiandussi L. Spontaneous release of interleukin 1 b from human blood monocytes in thyrotoxic osteodystrophy. J. Endocrinol. Invest. 1996, 16:511-515.
-
(1996)
J. Endocrinol. Invest.
, vol.16
, pp. 511-515
-
-
Bisbocci, D.1
Gallo, V.2
Damiano, P.3
Sidoli, L.4
Cantoni, R.5
Aimo, G.6
Priolo, G.7
Pagni, R.8
Chiandussi, L.9
-
6
-
-
0031023168
-
-
Lakatos P., Foldes J., Horvath C., Kiss L., Tatrai A., Takacs J., Tarjan G., Stem P.H. J. Clin. Endocrinol. Metab. 1997, 82:78-81.
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 78-81
-
-
Lakatos, P.1
Foldes, J.2
Horvath, C.3
Kiss, L.4
Tatrai, A.5
Takacs, J.6
Tarjan, G.7
Stem, P.H.8
-
7
-
-
10744226715
-
TSH is a negative regulator of skeletal remodeling
-
Abe E., Marians R.C., Yu W., Wu X., Ando T., Yanan L., Iqbal J., Eldeiry L., Rajendren G., Blair H.C., Davies T.F., Zaidi M. TSH is a negative regulator of skeletal remodeling. Cell 2003, 115:151-162.
-
(2003)
Cell
, vol.115
, pp. 151-162
-
-
Abe, E.1
Marians, R.C.2
Yu, W.3
Wu, X.4
Ando, T.5
Yanan, L.6
Iqbal, J.7
Eldeiry, L.8
Rajendren, G.9
Blair, H.C.10
Davies, T.F.11
Zaidi, M.12
-
8
-
-
0018748637
-
Osteoporosis in hyperthyroidism estimated by photon absorptiometry
-
Linde J., Friis T. Osteoporosis in hyperthyroidism estimated by photon absorptiometry. Acta. Endocrinolgica. 1979, 91:437-448.
-
(1979)
Acta. Endocrinolgica.
, vol.91
, pp. 437-448
-
-
Linde, J.1
Friis, T.2
-
9
-
-
0020583227
-
Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and anti-thyroid treatment
-
Krolner B., Jorgensen J.V., Nielsen S.P. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and anti-thyroid treatment. Clin. Endocrinol. 1983, 18:439-446.
-
(1983)
Clin. Endocrinol.
, vol.18
, pp. 439-446
-
-
Krolner, B.1
Jorgensen, J.V.2
Nielsen, S.P.3
-
10
-
-
0028153535
-
Thyrotoxic bone disease in women: a potentially reversible disorder
-
Diamond T., Vine J., Smart R., Butler P. Thyrotoxic bone disease in women: a potentially reversible disorder. Ann. Intern. Med. 1994, 120:8-11.
-
(1994)
Ann. Intern. Med.
, vol.120
, pp. 8-11
-
-
Diamond, T.1
Vine, J.2
Smart, R.3
Butler, P.4
-
11
-
-
0029907386
-
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole
-
Lupoli G., Nuzzo V., Di Carlo C., Affinito P., Vollery M., Vitale G., Cascone E., Arlotta F., Nappi C. Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. Gynecol. Endocrinol. 1996, 10:343-348.
-
(1996)
Gynecol. Endocrinol.
, vol.10
, pp. 343-348
-
-
Lupoli, G.1
Nuzzo, V.2
Di Carlo, C.3
Affinito, P.4
Vollery, M.5
Vitale, G.6
Cascone, E.7
Arlotta, F.8
Nappi, C.9
-
12
-
-
0031159059
-
Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism
-
Jodar E., Munoz-Torres M., Escobar-Jimenez F., Quesada M., Luna J.D., Olea N. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J. Clin. Endocrinol. Metab. 1997, 82:1989-1994.
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 1989-1994
-
-
Jodar, E.1
Munoz-Torres, M.2
Escobar-Jimenez, F.3
Quesada, M.4
Luna, J.D.5
Olea, N.6
-
13
-
-
0026716868
-
Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism
-
Rosen C.J., Adler R.A. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J. Clin. Endocrinol. Metab. 1992, 75:1531-1534.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 1531-1534
-
-
Rosen, C.J.1
Adler, R.A.2
-
14
-
-
0015225556
-
Osteoporosis and fractures following thyrotoxicosis
-
Fraser S.A., Anderson J.B., Smith D.A., Wilson G.M. Osteoporosis and fractures following thyrotoxicosis. Lancet 1971, 1:981-983.
-
(1971)
Lancet
, vol.1
, pp. 981-983
-
-
Fraser, S.A.1
Anderson, J.B.2
Smith, D.A.3
Wilson, G.M.4
-
15
-
-
0021846223
-
Effect of hyperthyroidism and its treatment on bone mineral content
-
Toh S.H., Claunch B.C., Brown P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Intern. Med. 1985, 145:883-886.
-
(1985)
Arch. Intern. Med.
, vol.145
, pp. 883-886
-
-
Toh, S.H.1
Claunch, B.C.2
Brown, P.H.3
-
16
-
-
0025278627
-
Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
-
Lee M.S., Kim S.Y., Lee M.C., Cho B.Y., Lee H.K., Koh C., Min H.K. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 1990, 70:766-770.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.70
, pp. 766-770
-
-
Lee, M.S.1
Kim, S.Y.2
Lee, M.C.3
Cho, B.Y.4
Lee, H.K.5
Koh, C.6
Min, H.K.7
-
17
-
-
8544225770
-
Antithyroid therapy improves bony manifestations and metabolic markers in patients with Graves' thyrotoxicosis
-
Nagasaka S., Sugimoto H., Nakamura T., Kusaka I., Fujisawa G., Sakuma N., Tsuboi Y., Fukuda S., Honda K., Okada K., Ishikawa S., Saito T. Antithyroid therapy improves bony manifestations and metabolic markers in patients with Graves' thyrotoxicosis. Clin. Endocrinol. 1997, 47:215-221.
-
(1997)
Clin. Endocrinol.
, vol.47
, pp. 215-221
-
-
Nagasaka, S.1
Sugimoto, H.2
Nakamura, T.3
Kusaka, I.4
Fujisawa, G.5
Sakuma, N.6
Tsuboi, Y.7
Fukuda, S.8
Honda, K.9
Okada, K.10
Ishikawa, S.11
Saito, T.12
-
18
-
-
0028240319
-
Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism
-
Legovini P., De Menis E., Rin G.D., Roiter I., Breda F., Artuso V., Di Virgilio R., Conte N. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism. Horm. Metab. Res. 1994, 26:334-337.
-
(1994)
Horm. Metab. Res.
, vol.26
, pp. 334-337
-
-
Legovini, P.1
De Menis, E.2
Rin, G.D.3
Roiter, I.4
Breda, F.5
Artuso, V.6
Di Virgilio, R.7
Conte, N.8
-
19
-
-
0027452608
-
The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover
-
MacLeod J.M., McHardy K.C., Harvey R.D., Duncan A., Reid I.W., Bewsher P.D., Robins S.P. The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin. Endocrinol. 1993, 38:49-53.
-
(1993)
Clin. Endocrinol.
, vol.38
, pp. 49-53
-
-
MacLeod, J.M.1
McHardy, K.C.2
Harvey, R.D.3
Duncan, A.4
Reid, I.W.5
Bewsher, P.D.6
Robins, S.P.7
-
20
-
-
0028220645
-
Urinary bone resorption markers in patients with metabolic bone disorders
-
Ohishi T., Kushida K., Takahashi M., Kawana K., Yagi K., Kawakami K., Horiuchi K., Inoue T. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994, 15:15-20.
-
(1994)
Bone
, vol.15
, pp. 15-20
-
-
Ohishi, T.1
Kushida, K.2
Takahashi, M.3
Kawana, K.4
Yagi, K.5
Kawakami, K.6
Horiuchi, K.7
Inoue, T.8
-
21
-
-
0028355131
-
Markers of bone turnover in hyperthyroidism and the effects of treatment
-
Garnero P., Vassy V., Bertholin A., Riou J.P., Delmas P.D. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab. 1994, 78:955-959.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.78
, pp. 955-959
-
-
Garnero, P.1
Vassy, V.2
Bertholin, A.3
Riou, J.P.4
Delmas, P.D.5
-
22
-
-
0028111183
-
Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
-
Garnero P., Gineyts E., Riou J.P., Delmas P.D. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J. Clin. Endocrinol. Metab. 1994, 79:780-785.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.79
, pp. 780-785
-
-
Garnero, P.1
Gineyts, E.2
Riou, J.P.3
Delmas, P.D.4
-
23
-
-
0022624721
-
Serum bone gla protein: a marker of bone tumover hyperthyroidism
-
Garrel D.R., Delmas P.D., Malaval L., Tourniaire J. Serum bone gla protein: a marker of bone tumover hyperthyroidism. J. Clin. Endocrinol. Metab. 1986, 62:1052-1055.
-
(1986)
J. Clin. Endocrinol. Metab.
, vol.62
, pp. 1052-1055
-
-
Garrel, D.R.1
Delmas, P.D.2
Malaval, L.3
Tourniaire, J.4
-
24
-
-
0028103839
-
Bone mineral density in thyroxine treated femals with our without a previous history of thyrotoxicosis
-
Franklyn J., Betteridge J., Holder R., Daykin J., Lilley J., Sheppard M. Bone mineral density in thyroxine treated femals with our without a previous history of thyrotoxicosis. Clin. Endocrinol. 1994, 41:425-432.
-
(1994)
Clin. Endocrinol.
, vol.41
, pp. 425-432
-
-
Franklyn, J.1
Betteridge, J.2
Holder, R.3
Daykin, J.4
Lilley, J.5
Sheppard, M.6
-
25
-
-
0025905961
-
Bone mineral density in postmenopausal women treated with L-thyroxine
-
Adlin E.V., Maurer A.H., Marks A.D., Channick B.J. Bone mineral density in postmenopausal women treated with L-thyroxine. Am. J. Med. 1991, 90:360-366.
-
(1991)
Am. J. Med.
, vol.90
, pp. 360-366
-
-
Adlin, E.V.1
Maurer, A.H.2
Marks, A.D.3
Channick, B.J.4
-
26
-
-
0025775569
-
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
-
Greenspan S.L., Greenspan F.S., Resnick N.M., Block J.E., Friedlander A.L., Genant H.K. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy. Am. J. Med. 1991, 91:5-14.
-
(1991)
Am. J. Med.
, vol.91
, pp. 5-14
-
-
Greenspan, S.L.1
Greenspan, F.S.2
Resnick, N.M.3
Block, J.E.4
Friedlander, A.L.5
Genant, H.K.6
-
27
-
-
0026751673
-
Peripheral bone density in women with untreated multinodular goitre
-
Mudde A.H., Reijnders F.J.S., Kruseman A.C.N. Peripheral bone density in women with untreated multinodular goitre. Clin. Endocrinol. 1992, 37:35-39.
-
(1992)
Clin. Endocrinol.
, vol.37
, pp. 35-39
-
-
Mudde, A.H.1
Reijnders, F.J.S.2
Kruseman, A.C.N.3
-
28
-
-
84882472285
-
Bone mineral content in premenopausal women with nontoxic goiter and reduced serum TSH
-
th meeting
-
Faber J., Overgaard K., Jarlow A. Bone mineral content in premenopausal women with nontoxic goiter and reduced serum TSH. Abstract 1 1992.
-
(1992)
Abstract 1
-
-
Faber, J.1
Overgaard, K.2
Jarlow, A.3
-
29
-
-
0027434963
-
Bone mineral density in patients with endogenous subclincal hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?
-
Foldes J., Tarjan G., Szathmari M., Varga F., Krasznai I., Horvath C.S. Bone mineral density in patients with endogenous subclincal hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?. Clin. Endocrinol. 1993, 39:521-527.
-
(1993)
Clin. Endocrinol.
, vol.39
, pp. 521-527
-
-
Foldes, J.1
Tarjan, G.2
Szathmari, M.3
Varga, F.4
Krasznai, I.5
Horvath, C.S.6
-
30
-
-
0031931052
-
Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism effect on bone loss in postmenopausal women
-
Faber J., Jensen W., Petersen L., Nygaard B., Hegedus L., Siersbaek-Nielsen K. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism effect on bone loss in postmenopausal women. Clin. Endocrinol. 1998, 48:285-290.
-
(1998)
Clin. Endocrinol.
, vol.48
, pp. 285-290
-
-
Faber, J.1
Jensen, W.2
Petersen, L.3
Nygaard, B.4
Hegedus, L.5
Siersbaek-Nielsen, K.6
-
31
-
-
0025057667
-
Bone gla protein and sex-hormone-binding globulin in nontoxic goiter parameters for metabolic status at the tissue level
-
Faber J., Perrild H., Johansen J.S. Bone gla protein and sex-hormone-binding globulin in nontoxic goiter parameters for metabolic status at the tissue level. J. Clin. Endocrinol. Metab. 1990, 70:49-55.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.70
, pp. 49-55
-
-
Faber, J.1
Perrild, H.2
Johansen, J.S.3
-
32
-
-
0034534237
-
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism
-
Kumeda Y., Inaba M., Tahara H., Kurioka Y., Ishikawa T., Morii H., Nishizawa Y. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 2000, 85:4157-4161.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, pp. 4157-4161
-
-
Kumeda, Y.1
Inaba, M.2
Tahara, H.3
Kurioka, Y.4
Ishikawa, T.5
Morii, H.6
Nishizawa, Y.7
-
33
-
-
0942276916
-
Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism
-
Kisakol G., Kaya A., Gonen S., Tunc R. Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism. Endocrine J. 2003, 50:657-661.
-
(2003)
Endocrine J.
, vol.50
, pp. 657-661
-
-
Kisakol, G.1
Kaya, A.2
Gonen, S.3
Tunc, R.4
-
34
-
-
1842333256
-
Decreased serum IGF-1 and dehydroepian drosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subelinical hyperthyroidism
-
Foldes J., Lakatos P., Zsadanyi J., Horvath C. Decreased serum IGF-1 and dehydroepian drosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subelinical hyperthyroidism. Eur. J. Endocrinol. 1997, 136:277-281.
-
(1997)
Eur. J. Endocrinol.
, vol.136
, pp. 277-281
-
-
Foldes, J.1
Lakatos, P.2
Zsadanyi, J.3
Horvath, C.4
-
35
-
-
84948726533
-
Exogenous Hyperthyroidism with osteoporosis
-
Fallon M.D., Perry H.M., Bergfeld M., Droke D., Teitelbaum S.L., Avioli L.V. Exogenous Hyperthyroidism with osteoporosis. Arch. Intern. Med. 1983, 143:442-444.
-
(1983)
Arch. Intern. Med.
, vol.143
, pp. 442-444
-
-
Fallon, M.D.1
Perry, H.M.2
Bergfeld, M.3
Droke, D.4
Teitelbaum, S.L.5
Avioli, L.V.6
-
36
-
-
0023624938
-
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine
-
Ross D.S., Neer R.M., Ridgway E.C., Daniels G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am. J. Med. 1987, 82:1167-1170.
-
(1987)
Am. J. Med.
, vol.82
, pp. 1167-1170
-
-
Ross, D.S.1
Neer, R.M.2
Ridgway, E.C.3
Daniels, G.H.4
-
37
-
-
0023890201
-
Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women
-
Paul T.L., Kerrigan J., Kelly A.M., Braverman L.E., Baran D.T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988, 259:3137-3141.
-
(1988)
JAMA
, vol.259
, pp. 3137-3141
-
-
Paul, T.L.1
Kerrigan, J.2
Kelly, A.M.3
Braverman, L.E.4
Baran, D.T.5
-
38
-
-
0025140523
-
Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine
-
Staff G.M., Harris S., Sokoll L.J., Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Annals. Int. Med. 1990, 113:265-269.
-
(1990)
Annals. Int. Med.
, vol.113
, pp. 265-269
-
-
Staff, G.M.1
Harris, S.2
Sokoll, L.J.3
Dawson-Hughes, B.4
-
39
-
-
0025880181
-
A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal woman with thyroid carcinoma
-
Diamond T., Nery L., Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal woman with thyroid carcinoma. J. Clin. Endocrinol. Metab. 1990, 72:1184-1188.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.72
, pp. 1184-1188
-
-
Diamond, T.1
Nery, L.2
Hales, I.3
-
40
-
-
0027496389
-
Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women
-
Kung A.W.C., Lorentz T., Tam S.C.F. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin. Endocrinol. 1993, 39:535-540.
-
(1993)
Clin. Endocrinol.
, vol.39
, pp. 535-540
-
-
Kung, A.W.C.1
Lorentz, T.2
Tam, S.C.F.3
-
41
-
-
0028324355
-
Thyroid hormone use and bone mineral density in elderly women
-
Schneider D.L., Barrett-Connor E.L., Morton D.J. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994, 271:1245-1249.
-
(1994)
JAMA
, vol.271
, pp. 1245-1249
-
-
Schneider, D.L.1
Barrett-Connor, E.L.2
Morton, D.J.3
-
42
-
-
0035486993
-
Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone
-
Sijanovic S., Karner I. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Medscape Womens Health 2001, 6:3-7.
-
(2001)
Medscape Womens Health
, vol.6
, pp. 3-7
-
-
Sijanovic, S.1
Karner, I.2
-
43
-
-
0025862046
-
Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH
-
Gam A.N., Jensen G.F., Hasselstrom K., Olsen M., Nielsen K.S. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH. J. Endocrinol. Invest. 1991, 14:451-455.
-
(1991)
J. Endocrinol. Invest.
, vol.14
, pp. 451-455
-
-
Gam, A.N.1
Jensen, G.F.2
Hasselstrom, K.3
Olsen, M.4
Nielsen, K.S.5
-
44
-
-
0026686399
-
Longterm thyroxine treatment and bone mineral density
-
Franklyn J.A., Betteridge J., Daykin J., Holder R., Oates G.D., Parle J.V., Lilley J., Heath D.A., Sheppard M.C. Longterm thyroxine treatment and bone mineral density. Lancet 1992, 340:9-13.
-
(1992)
Lancet
, vol.340
, pp. 9-13
-
-
Franklyn, J.A.1
Betteridge, J.2
Daykin, J.3
Holder, R.4
Oates, G.D.5
Parle, J.V.6
Lilley, J.7
Heath, D.A.8
Sheppard, M.C.9
-
45
-
-
0028131979
-
Bone density and mineral metabolism in thyroidectomized patients treated with long-term L-thyroxine
-
Giannini S., Nobile M., Sartori L., Binotto P., Ciuffreda M., Gemo G., Pelizzo M.R., D'Angelo A., Crepaldi G. Bone density and mineral metabolism in thyroidectomized patients treated with long-term L-thyroxine. Clin. Sci. 1994, 87:593-597.
-
(1994)
Clin. Sci.
, vol.87
, pp. 593-597
-
-
Giannini, S.1
Nobile, M.2
Sartori, L.3
Binotto, P.4
Ciuffreda, M.5
Gemo, G.6
Pelizzo, M.R.7
D'Angelo, A.8
Crepaldi, G.9
-
46
-
-
0028608803
-
Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy
-
Garton M., Reid I., Loveridge N., Robins S., Murchison L., Beckett G., Reid D. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Clin. Endocrinol. 1994, 41:747-755.
-
(1994)
Clin. Endocrinol.
, vol.41
, pp. 747-755
-
-
Garton, M.1
Reid, I.2
Loveridge, N.3
Robins, S.4
Murchison, L.5
Beckett, G.6
Reid, D.7
-
47
-
-
0030986513
-
Low thyrotropin levels are not associated with bone loss in older women: a prospective study
-
Bauer D.C., Nevitt M.C., Ettinger B., Stone K. Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J. Clin. Endocrinol. Metab. 1997, 82:2931-2936.
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 2931-2936
-
-
Bauer, D.C.1
Nevitt, M.C.2
Ettinger, B.3
Stone, K.4
-
48
-
-
0031744086
-
Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy
-
Nuzzo V., Lupoli G., Esposito Del Puente A., Rampone E., Carpinelli A., Del Puente A.E., Oriente P. Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy. Gynecol. Endocrinol. 1998, 12:333-337.
-
(1998)
Gynecol. Endocrinol.
, vol.12
, pp. 333-337
-
-
Nuzzo, V.1
Lupoli, G.2
Esposito Del Puente, A.3
Rampone, E.4
Carpinelli, A.5
Del Puente, A.E.6
Oriente, P.7
-
49
-
-
0025897209
-
Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism
-
Ross D.S., Ardisson L.J., Nussbaum S.R., Meskell M.J. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 1990, 72:507-509.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.72
, pp. 507-509
-
-
Ross, D.S.1
Ardisson, L.J.2
Nussbaum, S.R.3
Meskell, M.J.4
-
50
-
-
0035043983
-
Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism
-
Mikosch P., Jauk B., Gallowitsch H.J., Pipam W., Kresnik E., Lind P. Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism. Thyroid 2001, 11:257-263.
-
(2001)
Thyroid
, vol.11
, pp. 257-263
-
-
Mikosch, P.1
Jauk, B.2
Gallowitsch, H.J.3
Pipam, W.4
Kresnik, E.5
Lind, P.6
-
51
-
-
2642617814
-
Markers of bone tumover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy
-
Toivonen J., Tahtela R., Laitinen K., Risteli J., Valimaki M.J. Markers of bone tumover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy. Eur. J. Endocrinol. 1998, 138:667-673.
-
(1998)
Eur. J. Endocrinol.
, vol.138
, pp. 667-673
-
-
Toivonen, J.1
Tahtela, R.2
Laitinen, K.3
Risteli, J.4
Valimaki, M.J.5
-
52
-
-
0028296041
-
Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis
-
Faber J., Galloe A.M. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur. J. Endocrinol. 1994, 130:350-356.
-
(1994)
Eur. J. Endocrinol.
, vol.130
, pp. 350-356
-
-
Faber, J.1
Galloe, A.M.2
-
53
-
-
0029801045
-
Effects of bone mass of longterm treatment with thyroid hormones: a meta-analysis
-
Uzzan B., Campos J., Cucherat M., Nony P., Boissel J.P., Perret G.Y. Effects of bone mass of longterm treatment with thyroid hormones: a meta-analysis. J. Clin. Endocrinol. Metab. 1996, 81:4278-4289.
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 4278-4289
-
-
Uzzan, B.1
Campos, J.2
Cucherat, M.3
Nony, P.4
Boissel, J.P.5
Perret, G.Y.6
-
54
-
-
0025744590
-
Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers
-
Harvey R.D., McHardy K.C., Reid I.W., Paterson F., Bewsher P.D., Duncan A., Robins S.P. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J. Clin. Endocrinol. Metab. 1991, 72:1189-1194.
-
(1991)
J. Clin. Endocrinol. Metab.
, vol.72
, pp. 1189-1194
-
-
Harvey, R.D.1
McHardy, K.C.2
Reid, I.W.3
Paterson, F.4
Bewsher, P.D.5
Duncan, A.6
Robins, S.P.7
-
55
-
-
0026607837
-
Longitudinal study of bone loss after thyroidectomy and suppresseive thyroxine therapy in premenopausal women
-
Pioli G., Pedrazzoni M., Palummeri E., Sianesi M., Del Frate R., Vescovi P.P., Preisco M., Ulietti V., Costi D., Passeri M. Longitudinal study of bone loss after thyroidectomy and suppresseive thyroxine therapy in premenopausal women. Acta. Endocrinol. 1992, 126:238-242.
-
(1992)
Acta. Endocrinol.
, vol.126
, pp. 238-242
-
-
Pioli, G.1
Pedrazzoni, M.2
Palummeri, E.3
Sianesi, M.4
Del Frate, R.5
Vescovi, P.P.6
Preisco, M.7
Ulietti, V.8
Costi, D.9
Passeri, M.10
-
56
-
-
0030936418
-
Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine
-
Guo C.Y., Weetman A.P., Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin. Endocrinol. 1997, 46:301-307.
-
(1997)
Clin. Endocrinol.
, vol.46
, pp. 301-307
-
-
Guo, C.Y.1
Weetman, A.P.2
Eastell, R.3
-
57
-
-
0031784573
-
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
-
Rosen H.N., Moses A.C., Garber J., Ross D.S., Lee S.L., Ferguson L., Chen V., Lee K., Greenspan S.L. Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J. Clin. Endocrinol. Metab. 1998, 83:2324-2330.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 2324-2330
-
-
Rosen, H.N.1
Moses, A.C.2
Garber, J.3
Ross, D.S.4
Lee, S.L.5
Ferguson, L.6
Chen, V.7
Lee, K.8
Greenspan, S.L.9
-
58
-
-
0029866430
-
Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin
-
Kung A.W., Yeung S.S. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. J. Clin. Endocrinol. Metab. 1996, 81:1232-1236.
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 1232-1236
-
-
Kung, A.W.1
Yeung, S.S.2
-
59
-
-
0025027259
-
Effects of hormonal status on bone density in adolescent girls
-
Dhuper S., Warren M.P., Brooks-Gunn J., Fox R. Effects of hormonal status on bone density in adolescent girls. J. Clin. Endocrinol. Metab. 1990, 71:1083-1088.
-
(1990)
J. Clin. Endocrinol. Metab.
, vol.71
, pp. 1083-1088
-
-
Dhuper, S.1
Warren, M.P.2
Brooks-Gunn, J.3
Fox, R.4
-
60
-
-
0030038975
-
Role of growth hormone and sex steroids in achieving and maintaining normal bone mass
-
Holmes S.J., Shalet S.M. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm. Res. 1996, 45:86-93.
-
(1996)
Horm. Res.
, vol.45
, pp. 86-93
-
-
Holmes, S.J.1
Shalet, S.M.2
-
61
-
-
0024957154
-
The peak bone mass concept
-
Burckardt P., Michel C. The peak bone mass concept. Clin. Rheumatol. 1989, 8(Suppl 2):16-21.
-
(1989)
Clin. Rheumatol.
, vol.8
, Issue.SUPPL.2
, pp. 16-21
-
-
Burckardt, P.1
Michel, C.2
-
63
-
-
0025723535
-
Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element
-
Ernst M., Parkert M.G., Rodan G.A. Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol. Endocrinol. 1991, 5:1597-1606.
-
(1991)
Mol. Endocrinol.
, vol.5
, pp. 1597-1606
-
-
Ernst, M.1
Parkert, M.G.2
Rodan, G.A.3
-
64
-
-
0027174296
-
Cytokines and extrogen in bone: Anti-osteoporotic effects
-
Horowitz M.C. Cytokines and extrogen in bone: Anti-osteoporotic effects. Science 1993, 260:626-627.
-
(1993)
Science
, vol.260
, pp. 626-627
-
-
Horowitz, M.C.1
-
65
-
-
49749223893
-
A sex-chromosome anomaly in a case of gonadal dysgenesis (Tumer's Syndrome)
-
Ford C.E., Jones K.W., Polani P.E., de Almeida J.C., Briggs J.H. A sex-chromosome anomaly in a case of gonadal dysgenesis (Tumer's Syndrome). Lancet 1959, 1:711-713.
-
(1959)
Lancet
, vol.1
, pp. 711-713
-
-
Ford, C.E.1
Jones, K.W.2
Polani, P.E.3
de Almeida, J.C.4
Briggs, J.H.5
-
66
-
-
0015692990
-
Orthopedic aspects of the XO (Tumer's) syndrome
-
Beal R.K. Orthopedic aspects of the XO (Tumer's) syndrome. Clin. Orthopaed. Relat. Res. 1973, 97:19-30.
-
(1973)
Clin. Orthopaed. Relat. Res.
, vol.97
, pp. 19-30
-
-
Beal, R.K.1
-
67
-
-
0029562543
-
Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea
-
Davies M.C., Gulekli B., Jacobs H.S. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin. Endocrinol. 1995, 43:741-746.
-
(1995)
Clin. Endocrinol.
, vol.43
, pp. 741-746
-
-
Davies, M.C.1
Gulekli, B.2
Jacobs, H.S.3
-
68
-
-
0020397523
-
Skeletal dimenaralization in Tumer's syndrome
-
Shore R.M., Chesney R.W., Mazess R.B., Rose P.B., Bargman Skeletal dimenaralization in Tumer's syndrome. Calcif. Tissue Int. 1982, 34:519-522.
-
(1982)
Calcif. Tissue Int.
, vol.34
, pp. 519-522
-
-
Shore, R.M.1
Chesney, R.W.2
Mazess, R.B.3
Rose, P.B.4
Bargman5
-
69
-
-
0026605187
-
Effect of estrogen replacement therapy on bone mineral content in girls with Turner's syndrome
-
Mora S., Weber G., Guameri M.P., Nizzoli G., Pasolini D., Chiumello G. Effect of estrogen replacement therapy on bone mineral content in girls with Turner's syndrome. Obstet. Gynecol. 1992, 79:747-751.
-
(1992)
Obstet. Gynecol.
, vol.79
, pp. 747-751
-
-
Mora, S.1
Weber, G.2
Guameri, M.P.3
Nizzoli, G.4
Pasolini, D.5
Chiumello, G.6
-
70
-
-
0020026238
-
Bone demineralisation in patients with Turner's syndrome
-
Smith M.A., Wilson J., Price W.H. Bone demineralisation in patients with Turner's syndrome. J. Med. Genet. 1982, 19:100-103.
-
(1982)
J. Med. Genet.
, vol.19
, pp. 100-103
-
-
Smith, M.A.1
Wilson, J.2
Price, W.H.3
-
71
-
-
0026000858
-
Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome
-
Ross J.L., Long L.M., Feuillan P., Cassorla F., Cutler G.B. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. J. Clin. Endocrinol. Metab. 1991, 73:355-359.
-
(1991)
J. Clin. Endocrinol. Metab.
, vol.73
, pp. 355-359
-
-
Ross, J.L.1
Long, L.M.2
Feuillan, P.3
Cassorla, F.4
Cutler, G.B.5
-
72
-
-
0027520829
-
Turner's syndrome adolescents receiving growth hormone are not osteopenic
-
Neely E.K., Marcus R., Rosenfeld R.G., Bachrach L.K. Turner's syndrome adolescents receiving growth hormone are not osteopenic. J. Clin. Endocrinol. Metab. 1993, 76:861-866.
-
(1993)
J. Clin. Endocrinol. Metab.
, vol.76
, pp. 861-866
-
-
Neely, E.K.1
Marcus, R.2
Rosenfeld, R.G.3
Bachrach, L.K.4
-
73
-
-
0030827775
-
Bone longitudinal density in turmer's syndrome-a longitudinal study
-
Shaw N.J., Rehan V.K., Husain S., Marshall T., Smith C.S. Bone longitudinal density in turmer's syndrome-a longitudinal study. Clin. Endocrinol. 1997, 47:367-370.
-
(1997)
Clin. Endocrinol.
, vol.47
, pp. 367-370
-
-
Shaw, N.J.1
Rehan, V.K.2
Husain, S.3
Marshall, T.4
Smith, C.S.5
-
74
-
-
0034129248
-
A longitudinal study on bone mineral density until adulthood in grils with Turner's syndrome participating in a growth hormone injection frequency-response trial
-
Sass T.C., De Muinck Keizer-Schrama S.M., Stijnen T., Asarfi A., Van Leuwen W.J., Van Teunenbroek A., Van Rijn R.R., Drop S.L. A longitudinal study on bone mineral density until adulthood in grils with Turner's syndrome participating in a growth hormone injection frequency-response trial. Clin. Endocrinol. 2000, 52:531-536.
-
(2000)
Clin. Endocrinol.
, vol.52
, pp. 531-536
-
-
Sass, T.C.1
De Muinck Keizer-Schrama, S.M.2
Stijnen, T.3
Asarfi, A.4
Van Leuwen, W.J.5
Van Teunenbroek, A.6
Van Rijn, R.R.7
Drop, S.L.8
-
75
-
-
0027304654
-
Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte sub sets in premature ovarian failure and Turner's syndrome
-
Kurabayashi T., Yasuda M., Fujimaki T., Yamamoto Y., Oda K., Tanaka K. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte sub sets in premature ovarian failure and Turner's syndrome. Int. J. Gynecol. Obstet. 1993, 42:25-31.
-
(1993)
Int. J. Gynecol. Obstet.
, vol.42
, pp. 25-31
-
-
Kurabayashi, T.1
Yasuda, M.2
Fujimaki, T.3
Yamamoto, Y.4
Oda, K.5
Tanaka, K.6
-
76
-
-
0024558228
-
Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome
-
Stepan J.J., Musilova J., Pacovsky V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. J. Bone Min. Res. 1989, 4:193-198.
-
(1989)
J. Bone Min. Res.
, vol.4
, pp. 193-198
-
-
Stepan, J.J.1
Musilova, J.2
Pacovsky, V.3
-
77
-
-
0024349443
-
Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography
-
Louis O., Devroey P., Kalender W., Osteaux M. Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography. Fertil. Steril. 1989, 52:227-231.
-
(1989)
Fertil. Steril.
, vol.52
, pp. 227-231
-
-
Louis, O.1
Devroey, P.2
Kalender, W.3
Osteaux, M.4
-
78
-
-
0033814697
-
Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients
-
Carrascosa A., Gussinye M., Terradas P., Yeste D., Audi L., Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J. Bone Miner. Res. 2000, 15:2005-2010.
-
(2000)
J. Bone Miner. Res.
, vol.15
, pp. 2005-2010
-
-
Carrascosa, A.1
Gussinye, M.2
Terradas, P.3
Yeste, D.4
Audi, L.5
Vicens-Calvet, E.6
-
79
-
-
0346656715
-
The importance of estrogen replacement in young women with Turmer's syndrome
-
Hanton L., Axelrod L., Bakalov V., Bondy C.A. The importance of estrogen replacement in young women with Turmer's syndrome. J. Womens Health 2003, 12:971-977.
-
(2003)
J. Womens Health
, vol.12
, pp. 971-977
-
-
Hanton, L.1
Axelrod, L.2
Bakalov, V.3
Bondy, C.A.4
-
80
-
-
0025102639
-
Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy
-
Emans S.J., Grace E., Hoffer F.A., Gundberg C., Ravnikar V., Woods E.R. Estrogen deficiency in adolescents and young adults: Impact on bone mineral content and effects of estrogen replacement therapy. Obstet. Gynecol. 1990, 76:585-592.
-
(1990)
Obstet. Gynecol.
, vol.76
, pp. 585-592
-
-
Emans, S.J.1
Grace, E.2
Hoffer, F.A.3
Gundberg, C.4
Ravnikar, V.5
Woods, E.R.6
-
81
-
-
0028060326
-
Effect of treatment on established osteoporosis in young women with amenorrhoea
-
Gulekli B., Davies M.C., Jacobs H.S. Effect of treatment on established osteoporosis in young women with amenorrhoea. Clin. Endocrinol. 1994, 41:275-281.
-
(1994)
Clin. Endocrinol.
, vol.41
, pp. 275-281
-
-
Gulekli, B.1
Davies, M.C.2
Jacobs, H.S.3
-
82
-
-
0037932676
-
Bone mineral density in adult patients with Turner's syndrome: Analyses of the effectiveness of GH and ovarian steroid homone replacement therapies
-
Suganuma N., Furuhashi M., Hirooka T., Moriwaki T., Hasegawa Y., Mori O., Ogawa M. Bone mineral density in adult patients with Turner's syndrome: Analyses of the effectiveness of GH and ovarian steroid homone replacement therapies. Endocrine J. 2003, 50:263-269.
-
(2003)
Endocrine J.
, vol.50
, pp. 263-269
-
-
Suganuma, N.1
Furuhashi, M.2
Hirooka, T.3
Moriwaki, T.4
Hasegawa, Y.5
Mori, O.6
Ogawa, M.7
-
83
-
-
0347993153
-
Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency
-
Bakalov V.K., Axelrod L., Baron J., Hanton L., Nelson L.M., Reynolds J.C., Hill S., Troendle J., Bondy C.A. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J. Clin. Endocrinol. Metab. 2003, 88:5717-5722.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 5717-5722
-
-
Bakalov, V.K.1
Axelrod, L.2
Baron, J.3
Hanton, L.4
Nelson, L.M.5
Reynolds, J.C.6
Hill, S.7
Troendle, J.8
Bondy, C.A.9
-
84
-
-
0016221998
-
Osteoporosis in ovarian dysgenesis
-
Brown D.M., Jowsey J., Phil D., Bradford D.S. Osteoporosis in ovarian dysgenesis. J. Pediatr. 1974, 84:816-820.
-
(1974)
J. Pediatr.
, vol.84
, pp. 816-820
-
-
Brown, D.M.1
Jowsey, J.2
Phil, D.3
Bradford, D.S.4
-
85
-
-
0026732719
-
Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function
-
Saggese G., Federico G., Bertelloni S., Baroncelli G.I. Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function. J. Clin. Endocrinol. Metab. 1992, 75:998-1001.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 998-1001
-
-
Saggese, G.1
Federico, G.2
Bertelloni, S.3
Baroncelli, G.I.4
-
86
-
-
0025814554
-
Serum bone gla protein in streak gonad sydrome
-
Zseli J., Bosze P., Lakatos P., Vargha P., Tarjan G., Kollin E., Horvath C., Laszlo J., Hollo I. Serum bone gla protein in streak gonad sydrome. Calcif. Tissue Int. 1991, 48:387-391.
-
(1991)
Calcif. Tissue Int.
, vol.48
, pp. 387-391
-
-
Zseli, J.1
Bosze, P.2
Lakatos, P.3
Vargha, P.4
Tarjan, G.5
Kollin, E.6
Horvath, C.7
Laszlo, J.8
Hollo, I.9
-
87
-
-
0019456781
-
Urinary total hydroxiproline excretion in patients with Turner's sydroome and Klinefelter's syndrome
-
Jakubowski L. Urinary total hydroxiproline excretion in patients with Turner's sydroome and Klinefelter's syndrome. Horm. Metab. Res. 1981, 13:399-403.
-
(1981)
Horm. Metab. Res.
, vol.13
, pp. 399-403
-
-
Jakubowski, L.1
-
88
-
-
0028872902
-
Increased urinary excretion of collagen crosslinks in girls with Ullrich-Turner syndrome
-
Rauch F., Seibel M., Woitge H., Kruse K., Schonau E. Increased urinary excretion of collagen crosslinks in girls with Ullrich-Turner syndrome. Acta. Paediatr. 1995, 84:66-69.
-
(1995)
Acta. Paediatr.
, vol.84
, pp. 66-69
-
-
Rauch, F.1
Seibel, M.2
Woitge, H.3
Kruse, K.4
Schonau, E.5
-
89
-
-
0027270978
-
The somatotropin-somatomedin axis in adult patients with Turner syndrome: Measurements of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients
-
Holl R.W., Kunze D., Blum W.F., Benz R., Etzrodt H., Heinze The somatotropin-somatomedin axis in adult patients with Turner syndrome: Measurements of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients. Horm. Res. 1993, 39:30-53.
-
(1993)
Horm. Res.
, vol.39
, pp. 30-53
-
-
Holl, R.W.1
Kunze, D.2
Blum, W.F.3
Benz, R.4
Etzrodt, H.5
Heinze6
-
90
-
-
8244245760
-
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture
-
Barreca A., Larizza D., Damonte G., Arvigo M., Ponzani P., Cesarone A., Curto F., Severi F., Giordano G., Minuto F. Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with Turner's syndrome in culture. J. Clin. Endocrinol. Metab. 1997, 82:1041-1046.
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 1041-1046
-
-
Barreca, A.1
Larizza, D.2
Damonte, G.3
Arvigo, M.4
Ponzani, P.5
Cesarone, A.6
Curto, F.7
Severi, F.8
Giordano, G.9
Minuto, F.10
-
91
-
-
0028819596
-
Plasma growth hormone-binding protein activity, insulin like growth factor I, and its binding protein levels patpatients with Turner's syndrome: effect of short- and long-term recombinant growth hormone administration
-
Saggese G., Federico G., Cinquanta L. Plasma growth hormone-binding protein activity, insulin like growth factor I, and its binding protein levels patpatients with Turner's syndrome: effect of short- and long-term recombinant growth hormone administration. Pediatr. Res. 1995, 37:106-111.
-
(1995)
Pediatr. Res.
, vol.37
, pp. 106-111
-
-
Saggese, G.1
Federico, G.2
Cinquanta, L.3
-
92
-
-
0026757517
-
Growth hormone therapy in Turner's syndrome: an update on final heights
-
Rosenfeld R.G. Growth hormone therapy in Turner's syndrome: an update on final heights. Acta. Paediat. Scand. 1992, 383(Suppl):3-6.
-
(1992)
Acta. Paediat. Scand.
, vol.383
, Issue.SUPPL.
, pp. 3-6
-
-
Rosenfeld, R.G.1
-
93
-
-
84882517652
-
The effect of marathon training upon menstrual function
-
Shangold M.M., Levine H.S. The effect of marathon training upon menstrual function. Am. J. Obstet. Gynecol. 1979, 54:47.
-
(1979)
Am. J. Obstet. Gynecol.
, vol.54
, pp. 47
-
-
Shangold, M.M.1
Levine, H.S.2
-
95
-
-
0019135039
-
The effect of exercise on pubertal progression and reproductive functions in girls
-
Warren M.P. The effect of exercise on pubertal progression and reproductive functions in girls. J. Clin. Endocrinol. Metab. 1980, 51:1150-1157.
-
(1980)
J. Clin. Endocrinol. Metab.
, vol.51
, pp. 1150-1157
-
-
Warren, M.P.1
-
96
-
-
0022542903
-
Bone mineral content and levels of gonadotropins and estroges in amenorrheic running women
-
Fisher E.C., Nelson M.E., Fronteira W.R., Turksoy R.N., Evans W.J. Bone mineral content and levels of gonadotropins and estroges in amenorrheic running women. J. Clin. Endocrinol. Metab. 1986, 62:1232-1236.
-
(1986)
J. Clin. Endocrinol. Metab.
, vol.62
, pp. 1232-1236
-
-
Fisher, E.C.1
Nelson, M.E.2
Fronteira, W.R.3
Turksoy, R.N.4
Evans, W.J.5
-
97
-
-
0021275873
-
Bone mineral contend of amenorrheic and eumenorrheic athletes
-
Drikwater B.L., Nilson K., Chesnut C.H., Bremner W.J., Shainholtz S., Southworth M.B. Bone mineral contend of amenorrheic and eumenorrheic athletes. N. Engl. J. Med. 1984, 311:277-281.
-
(1984)
N. Engl. J. Med.
, vol.311
, pp. 277-281
-
-
Drikwater, B.L.1
Nilson, K.2
Chesnut, C.H.3
Bremner, W.J.4
Shainholtz, S.5
Southworth, M.B.6
-
98
-
-
0026642533
-
Total body bone density in amenorrheic runners
-
Myerson M., Gutin B., Warren M.P., Wang J., Lichtman S., Pierson R.N. Total body bone density in amenorrheic runners. Obstet. Gynecol. 1992, 79:973-978.
-
(1992)
Obstet. Gynecol.
, vol.79
, pp. 973-978
-
-
Myerson, M.1
Gutin, B.2
Warren, M.P.3
Wang, J.4
Lichtman, S.5
Pierson, R.N.6
-
99
-
-
0021951772
-
Menstrual function and bone mass in elite women distance runners
-
Marcus R., Cann C., Madvig P., Minkoff J., Goddard M., Bayer M., Martin M., Gaudiani L., Haskell W., Genant H. Menstrual function and bone mass in elite women distance runners. Ann. Inter. Med. 1985, 102:158-163.
-
(1985)
Ann. Inter. Med.
, vol.102
, pp. 158-163
-
-
Marcus, R.1
Cann, C.2
Madvig, P.3
Minkoff, J.4
Goddard, M.5
Bayer, M.6
Martin, M.7
Gaudiani, L.8
Haskell, W.9
Genant, H.10
-
100
-
-
0030018643
-
Bone density at multiple skeletal sites in amenorrheic athletes
-
Rencken M.L., Chesnut C.H., Drinkwater B.L. Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996, 276:238-240.
-
(1996)
JAMA
, vol.276
, pp. 238-240
-
-
Rencken, M.L.1
Chesnut, C.H.2
Drinkwater, B.L.3
-
101
-
-
0019967349
-
The differential effects of endocrine dysfunction on the axial and appendicular skeleton
-
Seeman E., Wahner H.W., Offord K.P., Johnson W.J., Riggs B.L. The differential effects of endocrine dysfunction on the axial and appendicular skeleton. J. Clin. Invest. 1982, 69:1302-1309.
-
(1982)
J. Clin. Invest.
, vol.69
, pp. 1302-1309
-
-
Seeman, E.1
Wahner, H.W.2
Offord, K.P.3
Johnson, W.J.4
Riggs, B.L.5
-
102
-
-
84995842587
-
Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effect of exercise, hypogonadism, and body weight
-
Young N., Formica C., Szmukler G., Seeman E. Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effect of exercise, hypogonadism, and body weight. J. Clin. Endocrinol. Metab. 1994, 78:449-454.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.78
, pp. 449-454
-
-
Young, N.1
Formica, C.2
Szmukler, G.3
Seeman, E.4
-
103
-
-
0028953822
-
Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea
-
Robinson T.L., Snow-Harter C., Taaffe D.R., Gillis D., Shaw J., Marcus R. Gymnasts exhibit higher bone mass than runners despite similar prevalence of amenorrhea and oligomenorrhea. J. Bone Min. Res. 1995, 10:26-35.
-
(1995)
J. Bone Min. Res.
, vol.10
, pp. 26-35
-
-
Robinson, T.L.1
Snow-Harter, C.2
Taaffe, D.R.3
Gillis, D.4
Shaw, J.5
Marcus, R.6
-
104
-
-
0027447266
-
High intensity activities in young women: Site specific bone mass effects among fenale figure skaters
-
Slemenda C.W., Johnston C.C. High intensity activities in young women: Site specific bone mass effects among fenale figure skaters. Bone Miner. Res. 1993, 20:125-132.
-
(1993)
Bone Miner. Res.
, vol.20
, pp. 125-132
-
-
Slemenda, C.W.1
Johnston, C.C.2
-
105
-
-
0005904392
-
Osteocalcin in young women with secondary amenorrhea
-
Takacs C., Solidum A.A., Zimmerli E.J., Warren M.P. Osteocalcin in young women with secondary amenorrhea. 1997 Society for Gynecologic Investigation, Annual Meeting 1997, 131.
-
(1997)
1997 Society for Gynecologic Investigation, Annual Meeting
, pp. 131
-
-
Takacs, C.1
Solidum, A.A.2
Zimmerli, E.J.3
Warren, M.P.4
-
106
-
-
11244250669
-
The assessment of bone metabolism in female elite endurance athletes by biochenical bone markers
-
Herrmann M., Herrmann W. The assessment of bone metabolism in female elite endurance athletes by biochenical bone markers. Clin. Chem. Lab. Med. 2004, 42:1384-1389.
-
(2004)
Clin. Chem. Lab. Med.
, vol.42
, pp. 1384-1389
-
-
Herrmann, M.1
Herrmann, W.2
-
107
-
-
0031814857
-
Relation between bone turnover, estradiol, and energy balance in women distance runners
-
Zanker C.L., Swaine I.L. Relation between bone turnover, estradiol, and energy balance in women distance runners. Br. J. Sports. Med. 1998, 32:167-171.
-
(1998)
Br. J. Sports. Med.
, vol.32
, pp. 167-171
-
-
Zanker, C.L.1
Swaine, I.L.2
-
108
-
-
0034700316
-
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa
-
Grinspoon S., Thomas E., Pitts S., Gross E., Mickley D., Miller K., Herzog D., Klibanski A. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann. Int. Med. 2000, 133:790-794.
-
(2000)
Ann. Int. Med.
, vol.133
, pp. 790-794
-
-
Grinspoon, S.1
Thomas, E.2
Pitts, S.3
Gross, E.4
Mickley, D.5
Miller, K.6
Herzog, D.7
Klibanski, A.8
-
110
-
-
0025086566
-
Reduced bone mineral in patients with eating disorders
-
Davies K.M., Pearson P.H., Huseman C.A., Greger N.G., Kimmel D.K., Reccker R.R. Reduced bone mineral in patients with eating disorders. Bone 1990, 11:143-147.
-
(1990)
Bone
, vol.11
, pp. 143-147
-
-
Davies, K.M.1
Pearson, P.H.2
Huseman, C.A.3
Greger, N.G.4
Kimmel, D.K.5
Reccker, R.R.6
-
111
-
-
0024581104
-
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa
-
Biller B.M.K., Saxe V., Herzog D.B., Rosenthal D.I., Holzman S., Klibansk A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J. Clin. Endocrinol. Metab. 1989, 68:548-554.
-
(1989)
J. Clin. Endocrinol. Metab.
, vol.68
, pp. 548-554
-
-
Biller, B.M.K.1
Saxe, V.2
Herzog, D.B.3
Rosenthal, D.I.4
Holzman, S.5
Klibansk, A.6
-
112
-
-
0029081214
-
Bone metabolism and osteopenia in eatingg disorders
-
Carmichael K.A., Carmichael D.H. Bone metabolism and osteopenia in eatingg disorders. Medicine 1995, 74:254-267.
-
(1995)
Medicine
, vol.74
, pp. 254-267
-
-
Carmichael, K.A.1
Carmichael, D.H.2
-
113
-
-
0028923621
-
The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa
-
Klibanski A., Biller B.M.K., Schoenfeld D.A., Herzog D.B., Saxe V.C. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J. Clin. Endocrinol. Metab. 1995, 80:898-904.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 898-904
-
-
Klibanski, A.1
Biller, B.M.K.2
Schoenfeld, D.A.3
Herzog, D.B.4
Saxe, V.C.5
-
114
-
-
0026030364
-
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass
-
Rigotti N.A., Neer R.M., Skates S.J., Herzog D.B., Nussbaum S.R. The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA 1991, 265:1133-1138.
-
(1991)
JAMA
, vol.265
, pp. 1133-1138
-
-
Rigotti, N.A.1
Neer, R.M.2
Skates, S.J.3
Herzog, D.B.4
Nussbaum, S.R.5
-
115
-
-
0029988235
-
Follow up of bone mineral density in 27 cases of anorexia nervosa
-
Maugars Y.M., Berthelot J.M.M., Forestier R., Mammar N., Ladande S., Venisse J.L., Prost A.M. Follow up of bone mineral density in 27 cases of anorexia nervosa. Euro. J. Endocrin. 1996, 135:591-597.
-
(1996)
Euro. J. Endocrin.
, vol.135
, pp. 591-597
-
-
Maugars, Y.M.1
Berthelot, J.M.M.2
Forestier, R.3
Mammar, N.4
Ladande, S.5
Venisse, J.L.6
Prost, A.M.7
-
116
-
-
4544357731
-
Preservation of neuroendocrine control of reproductive function despite severe undernutrition
-
Miller K.K., Grinspoon S., Gleysteen S., Grieco K.A., Ciampa J., Breu J., Herzog D.B., Klibanski A. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J. Clin. Endocrinol. Metab. 2004, 89:4434-4438.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 4434-4438
-
-
Miller, K.K.1
Grinspoon, S.2
Gleysteen, S.3
Grieco, K.A.4
Ciampa, J.5
Breu, J.6
Herzog, D.B.7
Klibanski, A.8
-
117
-
-
0023000663
-
Osteoporosis and hip fracture in a young woman with anorexia nervosa
-
Kaplan F.S., Pertschuck M., Fallon M., Haddad J. Osteoporosis and hip fracture in a young woman with anorexia nervosa. Clin. Orthop. 1986, 212:250-254.
-
(1986)
Clin. Orthop.
, vol.212
, pp. 250-254
-
-
Kaplan, F.S.1
Pertschuck, M.2
Fallon, M.3
Haddad, J.4
-
118
-
-
0025305043
-
Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation
-
Joyce J.M., Warren D.L., Humphries L.L., Smith A.J., Coon J.S. Osteoporosis in women with eating disorders: comparison of physical parameters, exercise, and menstrual status with SPA and DPA evaluation. J. Nucl. Med. 1990, 31:325-331.
-
(1990)
J. Nucl. Med.
, vol.31
, pp. 325-331
-
-
Joyce, J.M.1
Warren, D.L.2
Humphries, L.L.3
Smith, A.J.4
Coon, J.S.5
-
119
-
-
0023829260
-
Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa
-
Fonseca V.A., D'Souza V., Houlder S., Thomas M., Wakeling A., Dandona P. Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa. J. Clin. Pathol. 1988, 41:195-197.
-
(1988)
J. Clin. Pathol.
, vol.41
, pp. 195-197
-
-
Fonseca, V.A.1
D'Souza, V.2
Houlder, S.3
Thomas, M.4
Wakeling, A.5
Dandona, P.6
-
120
-
-
0029799208
-
Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa
-
Grinspoon S., Baum H., Lee K., Anderson E., Herzog D., Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J. Clin. Endocrinol. Metab. 1996, 81:3864-3870.
-
(1996)
J. Clin. Endocrinol. Metab.
, vol.81
, pp. 3864-3870
-
-
Grinspoon, S.1
Baum, H.2
Lee, K.3
Anderson, E.4
Herzog, D.5
Klibanski, A.6
-
121
-
-
0024619323
-
Osteoporose trabeculaire compliquant une anorexia mentale meconnue
-
Maugars Y., Prost A. Osteoporose trabeculaire compliquant une anorexia mentale meconnue. Rev. Rhum. Mal. Osteoartic. 1989, 56:159-161.
-
(1989)
Rev. Rhum. Mal. Osteoartic.
, vol.56
, pp. 159-161
-
-
Maugars, Y.1
Prost, A.2
-
122
-
-
4043137132
-
Effects of Risedronate on bone density in an orexia nervosa
-
Miller K.K., Grieco K.K., Mulder J.E., Grinspoon S., Mickley S., Yehezkel R., Herzog D.B., Klibanski A. Effects of Risedronate on bone density in an orexia nervosa. J. Clin. Endocrinol. Metab. 2004, 89:3903-3906.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 3903-3906
-
-
Miller, K.K.1
Grieco, K.K.2
Mulder, J.E.3
Grinspoon, S.4
Mickley, S.5
Yehezkel, R.6
Herzog, D.B.7
Klibanski, A.8
-
123
-
-
0035187205
-
Osteoporosis in eating disorders: A follow-up study of patients with anorexiaa and bulimia nervosa
-
Zipfel S., Seibel M.J., Lowe B., Beumont P.J., Kasperk C., Herzog W. Osteoporosis in eating disorders: A follow-up study of patients with anorexiaa and bulimia nervosa. J. Clin. Endocrinol Metab. 2001, 86:5227-5233.
-
(2001)
J. Clin. Endocrinol Metab.
, vol.86
, pp. 5227-5233
-
-
Zipfel, S.1
Seibel, M.J.2
Lowe, B.3
Beumont, P.J.4
Kasperk, C.5
Herzog, W.6
-
124
-
-
0017331377
-
Corisol secretion and metabolism in anorexia nervosaa
-
Boyar R.M., Hellman L.D., Roffwarg H., Kartz J., Zumoff B., O'Connor J., Bradlow H.L., Fukushima D.K. Corisol secretion and metabolism in anorexia nervosaa. N. Engl. J. Med. 1977, 296:190-193.
-
(1977)
N. Engl. J. Med.
, vol.296
, pp. 190-193
-
-
Boyar, R.M.1
Hellman, L.D.2
Roffwarg, H.3
Kartz, J.4
Zumoff, B.5
O'Connor, J.6
Bradlow, H.L.7
Fukushima, D.K.8
-
125
-
-
0021260628
-
Development of cushing's disease in patient with anorexia nervosa
-
Kontula K., Mustajoki P., Pelkonen R. Development of cushing's disease in patient with anorexia nervosa. J. Endocrinol. Invest. 1984, 7:35-40.
-
(1984)
J. Endocrinol. Invest.
, vol.7
, pp. 35-40
-
-
Kontula, K.1
Mustajoki, P.2
Pelkonen, R.3
-
126
-
-
0026775341
-
The effects of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
-
Counts D.R., Gwirtsman H., Carlsson L.M., Lesem M., Cutler G.B. The effects of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 1992, 75:762-767.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 762-767
-
-
Counts, D.R.1
Gwirtsman, H.2
Carlsson, L.M.3
Lesem, M.4
Cutler, G.B.5
-
127
-
-
0036078286
-
Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa
-
Grinspoon S., Thomas L., Miller K.K., Herzog D.B., Klibaski A. Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa. J. Clin. Endocrinol. Metab. 2002, 87:2883-2891.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 2883-2891
-
-
Grinspoon, S.1
Thomas, L.2
Miller, K.K.3
Herzog, D.B.4
Klibaski, A.5
-
128
-
-
0015788980
-
Epidemiology of secondary amenorrhea. Incidence and prevalence rates
-
Petersson F., Fries H., Nillius S.J. Epidemiology of secondary amenorrhea. Incidence and prevalence rates. Am. J. Obstet. Gynecol. 1973, 117:80-86.
-
(1973)
Am. J. Obstet. Gynecol.
, vol.117
, pp. 80-86
-
-
Petersson, F.1
Fries, H.2
Nillius, S.J.3
-
129
-
-
0022494409
-
Increase in bone mass after treatment of hyperprolactinemic amenorrhea
-
Klibanski A., Greenspan S.L. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 1986, 315:542-546.
-
(1986)
N. Engl. J. Med.
, vol.315
, pp. 542-546
-
-
Klibanski, A.1
Greenspan, S.L.2
-
131
-
-
0023846388
-
Vertebral bone density in non amenorrhoeic hyperprolactinaemic women
-
Ciccarelli E., Savino L., Carlevatto V., Bertagna A., Isaia G.C., Camanni F. Vertebral bone density in non amenorrhoeic hyperprolactinaemic women. Clin. Endocrinol. 1988, 28:1-6.
-
(1988)
Clin. Endocrinol.
, vol.28
, pp. 1-6
-
-
Ciccarelli, E.1
Savino, L.2
Carlevatto, V.3
Bertagna, A.4
Isaia, G.C.5
Camanni, F.6
-
132
-
-
15644381530
-
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males
-
Di Somma C., Colao A., Di Samo A., Klain M., Landi M.L., Facciollo G., Pivonello R., Panza N., Salvatore M., Lombardi G. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J. Clin. Endocrinol. Metab. 1998, 83:807-813.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 807-813
-
-
Di Somma, C.1
Colao, A.2
Di Samo, A.3
Klain, M.4
Landi, M.L.5
Facciollo, G.6
Pivonello, R.7
Panza, N.8
Salvatore, M.9
Lombardi, G.10
-
133
-
-
0026646936
-
Progressive trabecular osteopenia in women with hyperprolactinemic amenorheea
-
Biller B.M.K., Baum H.B.A., Rosenthal D.I., Saxe V.C., Charpie P.M., Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorheea. J. Clin. Endocrinol. Metab. 1992, 75:692-697.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 692-697
-
-
Biller, B.M.K.1
Baum, H.B.A.2
Rosenthal, D.I.3
Saxe, V.C.4
Charpie, P.M.5
Klibanski, A.6
-
134
-
-
0023218330
-
Forearm and vertebral bone mineral in treated and untreated hyperprolactinemia amenorrhea
-
Schlechte J., El-Khoury G., Kathol N., Walkner L. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemia amenorrhea. J. Clin. Endocrinol. Metab. 1987, 64:1021-1026.
-
(1987)
J. Clin. Endocrinol. Metab.
, vol.64
, pp. 1021-1026
-
-
Schlechte, J.1
El-Khoury, G.2
Kathol, N.3
Walkner, L.4
-
135
-
-
0023813607
-
Effects of prolactin and estrogen deficiency in amenorrheic bone loss
-
Klibanski A., Biller B.M.K., Rosenthal D.L., Schoenfeld D.A., Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J. Clin. Endocrinol. Metab. 1988, 67:124-130.
-
(1988)
J. Clin. Endocrinol. Metab.
, vol.67
, pp. 124-130
-
-
Klibanski, A.1
Biller, B.M.K.2
Rosenthal, D.L.3
Schoenfeld, D.A.4
Saxe, V.5
-
136
-
-
0021687231
-
Vertebral body bone mineral content in hyperprolactinemic women
-
Koppelman M.C.S., Kurtz D.W., Morrish K.A., Bou E., Susset J.K., Shapiro J.R., Loriax D.L. Vertebral body bone mineral content in hyperprolactinemic women. J. Clin. Endocrinol. Metab. 1994, 59:1050-1053.
-
(1994)
J. Clin. Endocrinol. Metab.
, vol.59
, pp. 1050-1053
-
-
Koppelman, M.C.S.1
Kurtz, D.W.2
Morrish, K.A.3
Bou, E.4
Susset, J.K.5
Shapiro, J.R.6
Loriax, D.L.7
-
137
-
-
0024509604
-
Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism
-
Greenspan S.L., Oppenheim D.S., Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann. Intern. Med. 1989, 110:526-531.
-
(1989)
Ann. Intern. Med.
, vol.110
, pp. 526-531
-
-
Greenspan, S.L.1
Oppenheim, D.S.2
Klibanski, A.3
-
138
-
-
0026783954
-
A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolatinemia
-
Schlechte J., Walkner L., Kathol M. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolatinemia. J. Clin. Endocrinol. Metab. 1992, 75:698-703.
-
(1992)
J. Clin. Endocrinol. Metab.
, vol.75
, pp. 698-703
-
-
Schlechte, J.1
Walkner, L.2
Kathol, M.3
-
139
-
-
0023228836
-
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression
-
Suva L.J., Winslow G.A., Wettenhall R.E.H., Hammonds R.G., Mosely J.M., Diefenbach-Jagger H., Rodda C.P., Kemp B.E., Rodriguez H., Chen E.Y. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987, 237:893-896.
-
(1987)
Science
, vol.237
, pp. 893-896
-
-
Suva, L.J.1
Winslow, G.A.2
Wettenhall, R.E.H.3
Hammonds, R.G.4
Mosely, J.M.5
Diefenbach-Jagger, H.6
Rodda, C.P.7
Kemp, B.E.8
Rodriguez, H.9
Chen, E.Y.10
-
140
-
-
0028787969
-
Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH- related peptide levels
-
Kovacs C.S., Chik C.L. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH- related peptide levels. J. Clin. Endocrinol. Metab. 1995, 80:3036-3042.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 3036-3042
-
-
Kovacs, C.S.1
Chik, C.L.2
-
141
-
-
0028917001
-
Plasma levels of parathyroid hormone-related peptide are elevated in hypeprolactinemia and correlated to bone density status
-
Stiegler C., Leb G., Kleinert R., Warnkross H., Ramschak-Schwarzer S., Lipp R., Clarici G., Krejs G.J., Dobnig H. Plasma levels of parathyroid hormone-related peptide are elevated in hypeprolactinemia and correlated to bone density status. J. Bone Min. Res. 1995, 10:751-759.
-
(1995)
J. Bone Min. Res.
, vol.10
, pp. 751-759
-
-
Stiegler, C.1
Leb, G.2
Kleinert, R.3
Warnkross, H.4
Ramschak-Schwarzer, S.5
Lipp, R.6
Clarici, G.7
Krejs, G.J.8
Dobnig, H.9
-
142
-
-
0025325120
-
Osteocalcin levels in patients with microprolactinoma before and during medical treatment
-
Sartorio A., Conti A., Ambrosi B., Muratori M., Faglia G. Osteocalcin levels in patients with microprolactinoma before and during medical treatment. J. Endocrinol. Invest. 1990, 13:419-422.
-
(1990)
J. Endocrinol. Invest.
, vol.13
, pp. 419-422
-
-
Sartorio, A.1
Conti, A.2
Ambrosi, B.3
Muratori, M.4
Faglia, G.5
-
144
-
-
1642484482
-
Bone health in pediatric epilepsy
-
Sheth R.D. Bone health in pediatric epilepsy. Epilepsy Behav. 2004, 5:S30-S35.
-
(2004)
Epilepsy Behav.
, vol.5
-
-
Sheth, R.D.1
-
145
-
-
0014940394
-
Osteomalacia with long-term anticonvulsant therapy in epilepsy
-
Dent C., Richens A., Rowe D.F.J., Stamp T. Osteomalacia with long-term anticonvulsant therapy in epilepsy. B.M.J. 1970, 4:69-72.
-
(1970)
B.M.J.
, vol.4
, pp. 69-72
-
-
Dent, C.1
Richens, A.2
Rowe, D.F.J.3
Stamp, T.4
-
146
-
-
0014940414
-
Disturbance of calcium metabolism by antocomvulsant drugs
-
Richens A., Rowe D.F.J. Disturbance of calcium metabolism by antocomvulsant drugs. B. M. J. 1970, 4:73-76.
-
(1970)
B. M. J.
, vol.4
, pp. 73-76
-
-
Richens, A.1
Rowe, D.F.J.2
-
147
-
-
0036094249
-
Antiepileptic drug-induced bone loss in young male patients who have seizures
-
Andress D.L., Ozuna J., Tirschwell D., et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch. Neurol. 2002, 59:781-786.
-
(2002)
Arch. Neurol.
, vol.59
, pp. 781-786
-
-
Andress, D.L.1
Ozuna, J.2
Tirschwell, D.3
-
148
-
-
0037076461
-
Effect of antiepileptic drugs on bone density in ambulatory patients
-
Farhat G., Yamout B., Mikati M.A., Demirjian S., Sawaya R., El Hajj Fuliehan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002, 58:1348-1353.
-
(2002)
Neurology
, vol.58
, pp. 1348-1353
-
-
Farhat, G.1
Yamout, B.2
Mikati, M.A.3
Demirjian, S.4
Sawaya, R.5
El Hajj Fuliehan, G.6
-
149
-
-
0033002623
-
Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study
-
Kubota F., Kifune A., Shibata N., Akata T., Takeuchi K., Takahashi S., Ohsawa M., Takama F. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res. 1999, 33:93-97.
-
(1999)
Epilepsy Res.
, vol.33
, pp. 93-97
-
-
Kubota, F.1
Kifune, A.2
Shibata, N.3
Akata, T.4
Takeuchi, K.5
Takahashi, S.6
Ohsawa, M.7
Takama, F.8
-
150
-
-
0038305810
-
Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs
-
Pack A.M., Olarte M., Morrell M.J., Flaster E., Resor S.R., Shane E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 2003, 4:169-174.
-
(2003)
Epilepsy Behav.
, vol.4
, pp. 169-174
-
-
Pack, A.M.1
Olarte, M.2
Morrell, M.J.3
Flaster, E.4
Resor, S.R.5
Shane, E.6
-
151
-
-
0035859862
-
Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy
-
Sato Y., Kondo I., Ishida S., et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001, 57:445-449.
-
(2001)
Neurology
, vol.57
, pp. 445-449
-
-
Sato, Y.1
Kondo, I.2
Ishida, S.3
-
152
-
-
0028292967
-
Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs
-
Valimaki M.J., Tiihonen M., Laitimen K., Tahtela R., Karkkainen M., Lamberg-Allardt C., Makela P., Tunninen R. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J. Bone Miner. Res. 1994, 9:631-637.
-
(1994)
J. Bone Miner. Res.
, vol.9
, pp. 631-637
-
-
Valimaki, M.J.1
Tiihonen, M.2
Laitimen, K.3
Tahtela, R.4
Karkkainen, M.5
Lamberg-Allardt, C.6
Makela, P.7
Tunninen, R.8
-
153
-
-
1642484481
-
Fractures, epilepsy, and anticonvulsant drugs
-
Mattson R.H., Gidal B.E. Fractures, epilepsy, and anticonvulsant drugs. Epilepsy Behav. 2004, 5:S36-S40.
-
(2004)
Epilepsy Behav.
, vol.5
-
-
Mattson, R.H.1
Gidal, B.E.2
-
154
-
-
0030042219
-
Incidence of five common fracture types in an institutional epileptic population
-
Desai K.B., Ribbans W.J., Taylor G.J. Incidence of five common fracture types in an institutional epileptic population. Injury 1996, 27:97-100.
-
(1996)
Injury
, vol.27
, pp. 97-100
-
-
Desai, K.B.1
Ribbans, W.J.2
Taylor, G.J.3
-
155
-
-
0032945492
-
Fracture risk is increased in epilepsy
-
Vestergaard P., Tigaran S., Rejnmark L., Tigaran C., Dam M., Mosekilde L. Fracture risk is increased in epilepsy. Acta. Neurol. Scand. 1999, 99:269-275.
-
(1999)
Acta. Neurol. Scand.
, vol.99
, pp. 269-275
-
-
Vestergaard, P.1
Tigaran, S.2
Rejnmark, L.3
Tigaran, C.4
Dam, M.5
Mosekilde, L.6
-
156
-
-
0036798939
-
Central nervous system-actvei medications and risk for falls in older women
-
Ensrud K.E., Blackwell T.L., Mangione C.M., et al. Central nervous system-actvei medications and risk for falls in older women. J. Am. Geriatr. Soc. 2002, 50:1629-1637.
-
(2002)
J. Am. Geriatr. Soc.
, vol.50
, pp. 1629-1637
-
-
Ensrud, K.E.1
Blackwell, T.L.2
Mangione, C.M.3
-
157
-
-
1642566108
-
Pathophysiology of bone loss in patients receiving anticonvulsant therapy
-
Fitzpatrick L.A. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav. 2004, 5:S3-S15.
-
(2004)
Epilepsy Behav.
, vol.5
-
-
Fitzpatrick, L.A.1
-
158
-
-
0017101258
-
Absorption and biotransformation of cholecalciferol in drug-induced osteomalacia
-
Matheson R.T., Herbst J.J., Jubiz W., Freston J.W., Tolman K.G. Absorption and biotransformation of cholecalciferol in drug-induced osteomalacia. J. Clin. Pharmacol. 1976, 16:426-432.
-
(1976)
J. Clin. Pharmacol.
, vol.16
, pp. 426-432
-
-
Matheson, R.T.1
Herbst, J.J.2
Jubiz, W.3
Freston, J.W.4
Tolman, K.G.5
-
159
-
-
0015492164
-
Effect of chronic anticonvulsant therapy on serum 25-hydroxycholecalciferol levels in adults
-
Hahn T.J., Hendin B.A., Scharp C.R., Haddad J.G. Effect of chronic anticonvulsant therapy on serum 25-hydroxycholecalciferol levels in adults. N. Engl. J. Med. 1972, 287:900-904.
-
(1972)
N. Engl. J. Med.
, vol.287
, pp. 900-904
-
-
Hahn, T.J.1
Hendin, B.A.2
Scharp, C.R.3
Haddad, J.G.4
-
160
-
-
0015318585
-
Phenobarbital induced alterations in vitamin D metabolism
-
Hahn T.J., Birge S.J., Scharp C.R., Avioli L.V. Phenobarbital induced alterations in vitamin D metabolism. J. Clin. Invest. 1972, 51:741-748.
-
(1972)
J. Clin. Invest.
, vol.51
, pp. 741-748
-
-
Hahn, T.J.1
Birge, S.J.2
Scharp, C.R.3
Avioli, L.V.4
-
161
-
-
0016662601
-
Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy
-
Hahn T.J., Hendin B.A., Scharp C.R., Boisseau V.C., Haddad J.J.G. Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N. Engl. J. Med. 1975, 292:550-554.
-
(1975)
N. Engl. J. Med.
, vol.292
, pp. 550-554
-
-
Hahn, T.J.1
Hendin, B.A.2
Scharp, C.R.3
Boisseau, V.C.4
Haddad, J.J.G.5
-
162
-
-
0015497261
-
Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs
-
Stamp T.C.B., Round J.M., Rowe D.J.F., Haddad J.J.G. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. B. M. J. 1972, 4:9-12.
-
(1972)
B. M. J.
, vol.4
, pp. 9-12
-
-
Stamp, T.C.B.1
Round, J.M.2
Rowe, D.J.F.3
Haddad, J.J.G.4
-
163
-
-
0022515632
-
A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy
-
Gough H., Goggin T., Bissessar A., Baker M., Crowlay M., Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q. J. Med. 1986, 230:569-577.
-
(1986)
Q. J. Med.
, vol.230
, pp. 569-577
-
-
Gough, H.1
Goggin, T.2
Bissessar, A.3
Baker, M.4
Crowlay, M.5
Callaghan, N.6
-
164
-
-
0019833266
-
Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy
-
Hoikka V., Savolainen K., Alhave E.M., Sivenius J., Karjalainen P., Repo A. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Acta. Neurol. Scand. 1981, 64:122-131.
-
(1981)
Acta. Neurol. Scand.
, vol.64
, pp. 122-131
-
-
Hoikka, V.1
Savolainen, K.2
Alhave, E.M.3
Sivenius, J.4
Karjalainen, P.5
Repo, A.6
-
165
-
-
0025817664
-
Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy
-
Okesina A.B., Donaldson D., Lascelles P.T. Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy. J. Clin. Pathol. 1991, 44:480-482.
-
(1991)
J. Clin. Pathol.
, vol.44
, pp. 480-482
-
-
Okesina, A.B.1
Donaldson, D.2
Lascelles, P.T.3
-
166
-
-
0021080595
-
Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin
-
Davie M.W., Emberson C.E., Lawson D.E., Roberts G.E., Barnes J.L., Barnes N.D., Heeleg A.F. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin. D. Q. J. Med. 1983, 205:79-91.
-
(1983)
D. Q. J. Med.
, vol.205
, pp. 79-91
-
-
Davie, M.W.1
Emberson, C.E.2
Lawson, D.E.3
Roberts, G.E.4
Barnes, J.L.5
Barnes, N.D.6
Heeleg, A.F.7
-
167
-
-
0019980298
-
Serum vitamin D metabolites in epileptic patients treated with 2 different anyconvulsants
-
Tjellesen L., Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anyconvulsants. Acta. Neurol. Scand. 1982, 66:335-341.
-
(1982)
Acta. Neurol. Scand.
, vol.66
, pp. 335-341
-
-
Tjellesen, L.1
Christiansen, C.2
-
168
-
-
0018581038
-
Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin
-
Wark J.D., Larkins R.G., Perry-Keene D., Peter C.T., Ross D.L., Sloman J.G. Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin. D. Clin. Endocrinol. 1979, 11:267-274.
-
(1979)
D. Clin. Endocrinol.
, vol.11
, pp. 267-274
-
-
Wark, J.D.1
Larkins, R.G.2
Perry-Keene, D.3
Peter, C.T.4
Ross, D.L.5
Sloman, J.G.6
-
169
-
-
0021238171
-
Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment
-
Weinstein R.S., Bryce G.F., Sappington L.J., King D.W., Gallagher B.B. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J. Clin. Endocrinol. Metab. 1984, 58:1003-1009.
-
(1984)
J. Clin. Endocrinol. Metab.
, vol.58
, pp. 1003-1009
-
-
Weinstein, R.S.1
Bryce, G.F.2
Sappington, L.J.3
King, D.W.4
Gallagher, B.B.5
-
170
-
-
13144282677
-
Bone metabolism and turnover in women with epilepsy on antiepileptic drug monotherapy
-
Pack A.M., Morrell M.J., Marcus R., Holloway L., Flaster E., Done E., Randall A., Seale C., Shane E. Bone metabolism and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann. Neurol. 2005, 57:252-257.
-
(2005)
Ann. Neurol.
, vol.57
, pp. 252-257
-
-
Pack, A.M.1
Morrell, M.J.2
Marcus, R.3
Holloway, L.4
Flaster, E.5
Done, E.6
Randall, A.7
Seale, C.8
Shane, E.9
-
171
-
-
0015466657
-
Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat
-
Koch H.C., Kraft D., Herrath D.V. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 1972, 13:829-841.
-
(1972)
Epilepsia
, vol.13
, pp. 829-841
-
-
Koch, H.C.1
Kraft, D.2
Herrath, D.V.3
-
172
-
-
0017046544
-
Inhibition of vitamin D-stimulated active transport of calcium of rat intestine by diphenylhydantoin phenobarbital treatment
-
Harrison H.C., Harrison H.E. Inhibition of vitamin D-stimulated active transport of calcium of rat intestine by diphenylhydantoin phenobarbital treatment. Proc. Soc. Exp. Biol. Med. 1976, 153:220-224.
-
(1976)
Proc. Soc. Exp. Biol. Med.
, vol.153
, pp. 220-224
-
-
Harrison, H.C.1
Harrison, H.E.2
-
173
-
-
0018697229
-
Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration
-
Hahn T.J., Halstead L.R. Anticonvulsant drug-induced osteomalacia: Alterations in mineral metabolism and response to vitamin D3 administration. Calcif. Tissue Int. 1979, 27:13-18.
-
(1979)
Calcif. Tissue Int.
, vol.27
, pp. 13-18
-
-
Hahn, T.J.1
Halstead, L.R.2
-
174
-
-
0018139085
-
Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hornonal mediation of fetal rat bone resorption in vitro
-
Hahn T.J., Scharp C.R., Richardson C.A., Halstead L.R., Kahn A.J., Teitelbaum S.L. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hornonal mediation of fetal rat bone resorption in vitro. J. Clin. Invest. 1978, 62:406-414.
-
(1978)
J. Clin. Invest.
, vol.62
, pp. 406-414
-
-
Hahn, T.J.1
Scharp, C.R.2
Richardson, C.A.3
Halstead, L.R.4
Kahn, A.J.5
Teitelbaum, S.L.6
-
175
-
-
0016217368
-
The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: Adenosine 3?, 5?-cyclic monophosphate production
-
Jenkins M.V., Harris M., Willis M.R. The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: Adenosine 3?, 5?-cyclic monophosphate production. Calcif. Tissue Res. 1974, 16:163-167.
-
(1974)
Calcif. Tissue Res.
, vol.16
, pp. 163-167
-
-
Jenkins, M.V.1
Harris, M.2
Willis, M.R.3
-
176
-
-
0018844367
-
Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture
-
Dietrich J.W., Duffield R. Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture. Endocrinology 1980, 106:606-610.
-
(1980)
Endocrinology
, vol.106
, pp. 606-610
-
-
Dietrich, J.W.1
Duffield, R.2
-
177
-
-
0032997194
-
Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report
-
Yamano Y., Sakane S., Takamatsu J., Ohsawa N. Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report. Endocr. J. 1999, 46:301-307.
-
(1999)
Endocr. J.
, vol.46
, pp. 301-307
-
-
Yamano, Y.1
Sakane, S.2
Takamatsu, J.3
Ohsawa, N.4
-
178
-
-
0026062955
-
Phenytoin-induced elevaion of serum estradiol and reproductive dysfunction in men with epilepsy
-
Heroz A.G., Levesque L.A., Drislane F.W., Ronthal M., Schomer D.L. Phenytoin-induced elevaion of serum estradiol and reproductive dysfunction in men with epilepsy. Epilepsia 1991, 32:550-553.
-
(1991)
Epilepsia
, vol.32
, pp. 550-553
-
-
Heroz, A.G.1
Levesque, L.A.2
Drislane, F.W.3
Ronthal, M.4
Schomer, D.L.5
-
179
-
-
0002959924
-
Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy
-
Mosekilde L., Melsen F. Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy. Metab. Bone Dis. Relat. Res. 1980, 2:77-82.
-
(1980)
Metab. Bone Dis. Relat. Res.
, vol.2
, pp. 77-82
-
-
Mosekilde, L.1
Melsen, F.2
-
180
-
-
0024537992
-
Increased circulating levels of a-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy
-
Takeshita N., Seino Y., Ishida H., Tanaka H., Tsutsumi C., Ogata K., Kiyohara K., Kato H., Nozawa M., Akiyama Y., Hara K., Imura H. Increased circulating levels of a-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy. Cacif. Tissue Int. 1989, 44:80-85.
-
(1989)
Cacif. Tissue Int.
, vol.44
, pp. 80-85
-
-
Takeshita, N.1
Seino, Y.2
Ishida, H.3
Tanaka, H.4
Tsutsumi, C.5
Ogata, K.6
Kiyohara, K.7
Kato, H.8
Nozawa, M.9
Akiyama, Y.10
Hara, K.11
Imura, H.12
-
181
-
-
0029112225
-
Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo
-
Lau K.H., Nakade O., Barr B., Taylor A.K., Houchin K., Baylink D.J. Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo. J. Clin. Endocrinol. Metab. 1995, 80:2347-2353.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2347-2353
-
-
Lau, K.H.1
Nakade, O.2
Barr, B.3
Taylor, A.K.4
Houchin, K.5
Baylink, D.J.6
-
182
-
-
0022978930
-
Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin
-
Tjellesen L., Hummer L., Christiansen C., Rodbro P. Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin. Bone 1986, 7:337-342.
-
(1986)
Bone
, vol.7
, pp. 337-342
-
-
Tjellesen, L.1
Hummer, L.2
Christiansen, C.3
Rodbro, P.4
-
183
-
-
0028220645
-
Urinary bone resorption markers in patients with metabolic bone disorders
-
Ohishi T., Kushida K., Takahashi M., Kawana K., Yagi K., Kwakami K., Horiuchi K., Inoue T. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994, 15:15-20.
-
(1994)
Bone
, vol.15
, pp. 15-20
-
-
Ohishi, T.1
Kushida, K.2
Takahashi, M.3
Kawana, K.4
Yagi, K.5
Kwakami, K.6
Horiuchi, K.7
Inoue, T.8
-
184
-
-
0034008836
-
Increased bone turnover in epileptic patients treated with carbamazepine
-
Verrotti A., Greco R., Morgese G., Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann. Neurol. 2000, 47:385-388.
-
(2000)
Ann. Neurol.
, vol.47
, pp. 385-388
-
-
Verrotti, A.1
Greco, R.2
Morgese, G.3
Chiarelli, F.4
-
185
-
-
0036896976
-
Increased bone turnover in prepubertal, pubertal and post-pubertal patients receiving carbamazepine
-
Verrotti A., Greco R., Latini G., Morgese G., Chiarelli F. Increased bone turnover in prepubertal, pubertal and post-pubertal patients receiving carbamazepine. Epilepsia 2002, 43:1488-1492.
-
(2002)
Epilepsia
, vol.43
, pp. 1488-1492
-
-
Verrotti, A.1
Greco, R.2
Latini, G.3
Morgese, G.4
Chiarelli, F.5
-
186
-
-
0029088857
-
Effect of carbamazepine and valproate on bone mineral density [see comments]
-
Sheth R.D., Wesolowski C.A., Jacob J.C., Penney S., Hobbs G.R., Riggs J.E., Bodensteiner J.B. Effect of carbamazepine and valproate on bone mineral density [see comments]. J. Pediatr. 1995, 127:256-262.
-
(1995)
J. Pediatr.
, vol.127
, pp. 256-262
-
-
Sheth, R.D.1
Wesolowski, C.A.2
Jacob, J.C.3
Penney, S.4
Hobbs, G.R.5
Riggs, J.E.6
Bodensteiner, J.B.7
-
187
-
-
1642566070
-
Treatment of anticonvulsant drug-induced bone disease
-
Drezner M.K. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 2004, 5:S41-S47.
-
(2004)
Epilepsy Behav.
, vol.5
-
-
Drezner, M.K.1
-
188
-
-
0018853236
-
Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation
-
Barden H.S., Mazess R.B., Rose P.G., McAweeney W. Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation. Calcif. Tissue Int. 1980, 31:117-121.
-
(1980)
Calcif. Tissue Int.
, vol.31
, pp. 117-121
-
-
Barden, H.S.1
Mazess, R.B.2
Rose, P.G.3
McAweeney, W.4
-
189
-
-
0026011883
-
A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia
-
Collins N., Maher J., Cole M., Baker M., Callaghan N. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Quart. J. Med. 1991, 78:113-122.
-
(1991)
Quart. J. Med.
, vol.78
, pp. 113-122
-
-
Collins, N.1
Maher, J.2
Cole, M.3
Baker, M.4
Callaghan, N.5
|